Constitutive c-myc expression suppresses cell cycle arrest, promotes entry into S phase, and results in the growth factor-independent expression of ornithine decarboxylase (ODC; EC 4.1.1.17). The ODC gene contains a conserved repeat of the Myc binding site, CACGTG, in intron 1. In this report, we demonstrate that c-Myc is a potent transactivator of ODC promoter-reporter gene constructs in fibrobLsts that requires the CACGTG repeat. These sites conferred Myc responsiveness on heterologous promoter constructs, suggesting that ODC is regulated by Myc at the level of tnscription initiation. Analysis of deletion and point mutants of c-myc revealed that domains required for bansactivation of the ODC promoter did not include the leucine zipper of the Myc protein. This suggests that Myc may interact with transcription factors other than Max to transactivate the ODC gene.
The c-myc protooncogene is a key regulator of cell growth and differentiation. c-myc expression is tightly associated with growth in multiple cell types and is universally induced by mitogens and down-regulated by growth-inhibitory agents (1). Removal of Myc protein appears necessary for withdrawal from the cell cycle, since enforced c-myc expression promotes cell cycle progression (2, 3) . Myc-family proteins contain several motifs characteristic of known transcription factors, including proline-, glutamine-, and acid-rich regions, a basic-helix-loop-helix (B-HLH) motif, and a leucine zipper (LZ) (1). Myc has sequence-specific DNA-binding activity (4, 5) and binds with high affinity to the "E-box" motif, CACGTG, through its association with a B-HLH-LZ partner, Max (6). Moreover, c-Myc is capable of transactivating reporter genes having a repeated array of synthetic CACGTG motifs in mammalian cells (7). By contrast, Max functions as a repressor of transcription in these assays; repression can be relieved by cotransfection of c-myc expression vectors (7).
The identification of genes that are direct targets of Myc has remained elusive. We have reasoned that promotion of cell cycle progression by Myc is due to transcriptional activation of gene targets which are required for entry into S phase. One of the enzymes necessary for progression into S phase is ornithine decarboxylase (ODC; EC 4.1.1.17), the rate-limiting enzyme of polyamine biosynthesis. Specific inhibitors of ODC enzyme activity, or polyamine depletion, arrest cells in G1 (8) . Enforced c-myc expression in interleukin 3 (IL-3)-dependent murine myeloid cell lines results in constitutive, IL-3-independent, expression of ODC RNA (2, 9). Multiple copies of the ODC gene occur in mammalian genomes, but only one directs enzyme synthesis (10). The murine ODC gene contains two potential Myc binding sites, CACGTG, within the first intron (Fig. 1A) . These binding sites are conserved in mammals (Fig. 1B) . In this report we show that Myc is a potent transactivator of ODC transcription.
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MATERIALS AND METHODS Cells. NIH 3T3 clone 7 fibroblasts were maintained as described (14) .
Transfections and Chloramphenicol Acetyltransferse (CAT) Assays. Calcium phosphate-mediated transfections and CAT assays were performed by standard protocols. Transfections were normalized for total DNA content by using pUC18, and 10-20 pg of cytosolic extract was used for each CAT assay.
Promoter CAT Constructs and Expression Plasmids. The murine ODC-CAT gene fusion constructs pODC CAT and pODCACAT (14) (Fig. 1A) . The products of the amplification reactions were also used as a template in a second round of PCR amplification to create the double mutant ODCACATASMB1/MB2.M1. Double-stranded oligonucleotides containing the core and flanking sequences of MB1 (TGCGGCCACGTGTCGCGA) and MB2 (AGGGGACACGTGGCCCGG) were ligated into pBLCAT2, which contains a minimal herpes simplex virus 1 thymidine kinase (TK) promoter (15). Mutant oligonucleotides having a single mutation in each ofthe Myc binding sites (CACCTG) were cloned in the same way. In addition, a double-stranded oligonucleotide (ODC MB1/MB2), containing ODC nt +228 to +281 (Fig. 1B) , spanning both of the CACGTG motifs, was cloned as above. The structures of these constructs were confirmed by sequencing.
The human c-myc expression plasmid pM21 (driven by the long terminal repeat of Moloney murine leukemia virus) and its deletion derivatives, the murine c-myc expression plasmid pSV2c-myc, the point mutants of the c-myc LZ domain, and expression vectors containing point mutations within the human c-myc basic region and helix I have been described (5, 16, 17) .
In Vitro Transcription/Translation and Electrophoretic Mobility-Shift Assays. The transcription plasmids pHLmycO/1 and pVZ21-MAX were a gift of R. Eisenman (Fred Hutchinson Cancer Center, Seattle). Linearized plasmids were transcribed in vitro and the RNA produced was translated in rabbit reticulocyte lysate (Promega). Dimerization of programmed reticulocyte lysates and the reaction conditions for complex formation were as described (18). Double-stranded oligonucleotide probes (0.25 ng) spanning MB1 and its mutant derivative were as above.
Abbreviations: ODC, ornithine decarboxylase; CAT, chloramphenicol acetyltransferase; LZ, leucine zipper; B-HLH, basic-helixloop-helix; MBn, Myc binding site n; IL-3, interleukin 3; TK, thymidine kinase. *To whom reprint requests should be addressed. (Fig.  1A) . Cotransfection experiments demonstrated that Myc was a potent activator of both ODC promoter constructs in fibroblasts (4100-fold induction; Fig. 1C) , and had moderate effects in 32D myeloid cells (3-to 4-fold; data not shown). Since ODCA&CAT was as active as ODC CAT, the Mycresponsive element(s) were within sequences contained in ODCACAT. Activation of ODCACAT was dependent upon Myc function since transient cotransfection with several constructs expressing mutant forms of Myc failed to promote CAT activity (see below).
To demonstrate that transactivation of ODC specifically required the conserved Myc binding sequences, site directed mutagenesis was performed. The core CACGTG sequence of MB1 and MB2 was altered to CACCTG in each binding site singularly and in tandem. These mutations greatly reduced the affinity of Myc (see below) for these sites. Mutant binding sites were tested for Myc responsiveness in the context of ODCACATAS (Fig. 1A) , which is equivalent to ODCA&CAT as a Myc target (Fig. 1D) . Mutation of MB1 or MB2 alone diminished by a factor of 3-5 the ability of Myc to transactivate the promoter. By contrast, mutation of both binding sites abolished transactivation of this construct (Fig. 1D) . Therefore, Myc-mediated transactivation of the ODC promoter requires these conserved Myc binding sites.
Myc-Responsive Elements of the ODC Gene Confer Responsiveness on a Heterologous Promoter. The position of the Myc binding sites suggested that Myc could influence ODC promoter-CAT activity by affecting RNA processing, transcription elongation, or transcription initiation. To address the last possibility, oligonucleotides spanning MB1, MB2, or both MB1 and MB2 were cloned 5' of the minimal TK promoter of pBLCAT2 (MB1 CAT, MB2 CAT, and ODC MB1/MB2 CAT; Fig. 2 ). The mutant versions ofMB1 and MB2 described above were similarly cloned to give MBl.M1 CAT and MB2.M1 CAT, respectively (Fig. 2) . c-myc cotransfection had little effect upon minimal TK promoter activity yet was an effective transactivator of MB1 and MB2 CAT (13-and 12-fold induction) and was even more effective in transactivating ODC MB1/MB2 (27-fold induction). By Max r be supershifted with Max-specific antiserum (data not shown). Two additional Max-containing complexes were detected with human Max-programmed lysates. Myc was capable of binding as two slower migrating complexes; this binding was presumably dependent upon endogenous rabbit Max, as the same complexes were much more abundant when the probe was incubated with programmed lysates in which Myc and Max had been allowed to dimerize (Fig. 3A) . All four complexes were specific for the core CACGTG sequence, as they had higher affinity for the wild-type oligonucleotide than for one containing a single base change in this sequence, to CACCTG (Fig. 3B) . The identity of these complexes was established with supershift experiments with Myc-and Max-specific antibodies (data not shown).
Domains of Myc Required for Transactivation of the ODC Gene. To define the domains of Myc necessary for transactivation of the ODC gene, we tested a series of characterized human c-myc deletion mutants (16) and B-HLH and LZ point mutants of human and murine c-myc (5, 17) in transient cotransfection assays with ODCACAT (Fig. 4A) . Removal or mutation of several domains shown to be necessary for transformation (such as the B-HLH region; refs. 5 and 16) or which function as transactivation domains (amino terminus, aa 7-53 and 93-201; ref. 20) resulted in loss of activity (Fig.  4A) . By contrast, removal of other specific regions in the amino terminus (aa 56-103 and 106-143) and portions of the central third of human Myc (aa 145-262) increased transactivating activity of Myc (Fig. 4A) . The failure of some ofthese constructs to transactivate and of others to activate A ODCACAT was not generally attributable to differences in protein levels. Western blot analysis of stably transfected NIH 3T3 cells with 9E10, a monoclonal antibody specific for human Myc, revealed comparable levels of the predicted sizes (16) of Myc polypeptides (Fig. 4B) . The HLH and LZ deletion mutants could not be detected with this antibody (since the epitope spans this region) but are expressed at comparable levels in COS cells (16).
Interestingly, a deletion (D414-433) which removes Leu420 and Leu427, takes Leu434 out of context, and compromises transforming activity (16) did not alter Myc transactivation. However, D414-433 Myc protein made in reticulocyte lysates, with or without Max, failed to bind to MB1 (Fig. 3A) . This suggests that Myc transactivates ODCACAT independent of Max.
To evaluate the importance of the specific leucine residues within the LZ domain to ODC transactivation, we tested point mutants of the murine Myc LZ domain (17) . Mutants in which Leu420 and Leu427 were converted to tryptophan and serine, respectively, were as active as the wild-type protein in transactivation (Fig. 5) . By contrast, the helix-breaking mutation of Leu4" to proline, or mutation of all four leucines (L413-433PWSP), abolished transactivation (Fig. 5) .
DISCUSSION
The ODC gene is an appealing transcriptional target for Myc since ODC is also required for G1 progression and transformation (8, 21). In addition, ODC expression is regulated as an early gene product, follows c-myc induction by (22) . Therefore, the requirements of specific domains for Mycmediated transformation may not necessarily reflect those required for growth or activation of gene expression.
The most surprising region dispensable for Myc transactivation of ODC promoter constructs was a large portion of the LZ domain (D414-433), which is required for interaction with Max (Fig. 3A) and for transformation (16) . Similarly, the specific mutations ofLeu413, Leu420, and Leu427 all drastically reduce the ability of Myc to inhibit murine erythroleukemia cell differentiation (17) , although D414-433 in fact accelerates differentiation of these same cells (22) . We have shown that the last three leucines of the Myc LZ domain are dispensable for transactivation of the ODC promoter, whereas the first leucine (Leu413), juxtaposed to the B-HLH domain, is required. This may reflect the nature of the L413P mutation, which introduced a helix-breaking proline, versus those at Leu420 and Leu427, which may not break the proposed a-helical structure. The Myc LZ domain is required for formation of homodimers (23), for dimerization with Max both in vitro (6) and in vivo (24), and for binding of an in vitro translated Myc/Max complex to an oligonucleotide containing the CACGTG motif (Fig. 3 and ref. 6 
